Literature DB >> 3327632

The structural relationship of blood group-related oligosaccharides in human carcinoma to biological function: a perspective.

V E Dube1.   

Abstract

Blood group-related oligosaccharides have been isolated from a limited number of carcinomas. The carcinoma-associated oligosaccharides show chain elongation, for example due to repeating Gal 1,4 GlcNAc 1,3 sequences, or a higher degree of branching, which permit increased sialylation and fucosylation. Abnormal carbohydrate structures have been demonstrated on tumor cell membranes by immunological techniques, which suggests deletion of ABH, accumulation of 'crypt' antigens such as I and T antigens, and abnormal expression of Lewis antigens. Changes in carcinoma-associated oligosaccharides can result from altered biosynthetic processing in the Golgi apparatus or the occurrence of abnormal tumor glycosyltransferase isoenzymes. Structural alterations of oligosaccharides on the tumor cell membrane are related to the regulation of tumor growth, cell-cell interaction, cell differentiation, and metastasis. Glycoproteins secreted by tumor cells into the circulation evoke cellular and humoral immunity and cause immune suppression by binding to cytotoxic T lymphocytes and lymphocyte subsets. The relationship of oligosaccharide structures to biologic function awaits elucidation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3327632     DOI: 10.1007/bf00047467

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  112 in total

Review 1.  Plasma protein measurements as a diagnostic aid.

Authors:  C A Alper
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

2.  Serum protein-bound fucose in patients with gynecologic cancers.

Authors:  J J Barlow; P H Dillard
Journal:  Obstet Gynecol       Date:  1972-05       Impact factor: 7.661

Review 3.  The role of polyprenol-linked sugars in glycoprotein synthesis.

Authors:  C J Waechter; W J Lennarz
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

Review 4.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

5.  Carbon-13 nuclear magnetic resonance studies on lectin-carbohydrate interactions: binding of specifically carbon-13-labeled methyl beta-D-lactoside to peanut agglutinin.

Authors:  K J Neurohr; H H Mantsch; N M Young; D R Bundle
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

6.  Red blood cell cold agglutinins and B lymphocyte cytotoxins in breast cancer sera.

Authors:  V Dube; Y Iwaki; B Anderson; P Terasaki
Journal:  Vox Sang       Date:  1982       Impact factor: 2.144

7.  Carcinoembryonic antigen, a tumor-associated glycoprotein induces defective lymphocyte function.

Authors:  A A Hakim
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

8.  The combination of normal-phase and reverse-phase high-pressure liquid chromatography with NMR for the isolation and characterization of oligosaccharide alditols from ovarian cyst mucins.

Authors:  V K Dua; V E Dube; C A Bush
Journal:  Biochim Biophys Acta       Date:  1984-11-06

9.  Marker half-life analysis as a prognostic tool in testicular cancer.

Authors:  P H Lange; N J Vogelzang; A Goldman; B J Kennedy; E E Fraley
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

10.  Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.

Authors:  J M Decker; A Hinson; E W Ades
Journal:  J Clin Lab Immunol       Date:  1984-11
View more
  2 in total

Review 1.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients.

Authors:  I Shimada; M Shoji; R Futatsuya; T Katoh; Y Kominato; T Sakamoto; T Fujikura
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.